First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults
Clinical trial NCT07646353 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07646353
- Sponsor
- GlaxoSmithKline
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-12
- Primary completion
- 2028-04-19
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.